| Literature DB >> 34271975 |
Jia-Jie Liang1,2,3, Hu Peng2,4, Jiao-Jiao Wang1, Xiao-Hui Liu1, Lan Ma1,2,3, Yi-Ran Ni1,2,3, Huai-Jie Yang5, Yan-Qiong Zhang1,2,3, Wen-Bing Ai6, Jiang-Feng Wu7,8,9,10,11.
Abstract
E proteins are transcriptional regulators that regulate many developmental processes in animals and lymphocytosis and leukemia in Homo sapiens. In particular, E2A, a member of the E protein family, plays a major role in the transcriptional regulatory network that promotes the differentiation and development of B and T lymphocytes. E2A-mediated transcriptional regulation usually requires the formation of E2A dimers, which then bind to coregulators. In this review, we summarize the mechanisms by which E2A participates in transcriptional regulation from a structural perspective. More specifically, the C-terminal helix-loop-helix (HLH) region of the basic HLH (bHLH) domain first dimerizes, and then the activation domains of E2A bind to different coactivators or corepressors in different cell contexts, resulting in histone acetylation or deacetylation, respectively. Then, the N-terminal basic region (b) of the bHLH domain binds to or dissociates from a specific DNA motif (E-box sequence). Last, trans-activation or trans-repression occurs. We also summarize the properties of these E2A domains and their interactions with the domains of other proteins. The feasibility of developing drugs based on these domains is discussed.Entities:
Keywords: Activation domain; E2A; Structural basis; bHLH domain
Year: 2021 PMID: 34271975 DOI: 10.1186/s40709-021-00146-5
Source DB: PubMed Journal: J Biol Res (Thessalon) ISSN: 1790-045X Impact factor: 1.889